Jaguar Health, Inc. Form 8-K Summary
Business Context and Reporting Period
This Form 8-K was filed by Jaguar Health, Inc. (JAGX) on August 11, 2020. The filing serves as a current report to announce a scheduled conference call for August 13, 2020, to discuss second-quarter 2020 financial results and provide business updates. The company is incorporated in Delaware and trades on the NASDAQ Capital Market.
Key Financial Metrics
The filing text does not provide specific values for revenue, profit, cash flow, margins, debt, or liquidity. This document is a procedural announcement regarding an upcoming earnings call rather than a financial statement.
Material Changes
No material financial changes or operational updates are detailed within this specific filing. The document solely references the upcoming release of second-quarter 2020 financials.
Guidance, Outlook, and Risks
Management has scheduled a conference call for Thursday, August 13, 2020, at 8:30 a.m. ET to review financials and provide business updates. The filing explicitly states that the press release furnished as Exhibit 99.1 is not deemed "filed" for purposes of Section 18 of the Exchange Act and is not incorporated by reference into other filings unless expressly stated.
Investor Verification Checklist
- Verify the date and time of the earnings conference call (August 13, 2020, 8:30 a.m. ET).
- Review the press release attached as Exhibit 99.1 for preliminary details.
- Monitor the upcoming Q2 2020 earnings release for actual financial metrics, as they are not included in this 8-K.
- Confirm the company's status as an emerging growth company that has elected not to use the extended transition period for new accounting standards.